With the X-ray vision of DESY's light source DORIS, researchers from Hamburg and Iceland have deciphered the molecular structure of a master regulator central to melanoma, the most deadly form of skin cancer. These findings could be important for the development of tailor made drugs targeting the so-called MITF.
